GNPX

Genprex Inc

NASDAQ: GNPX · HEALTHCARE · BIOTECHNOLOGY

$0.85

-2.08% today

Updated 2026-06-03

Market cap

$6.85M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-5.06

Dividend yield

—

52W range

$1 – $55

Volume

0.7M

Market cap

$6.85M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-5.06

Dividend yield

—

52W range

$1 – $55

Volume

0.7M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$7.50

+781.21%

12-Month target

$4.25

+399.35%

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-3.14M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-23.74M	$-30.86M	$-21.11M	$-16.23M	$-4.46M
EPS	—	—	—	—	$-5.06
Free cash flow	$-17.78M	$-24.81M	$-17.15M	$-15.31M	$-3.14M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
GNPX	$6.85M	26	4.3	3.0	5.0	6.0	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Genprex Inc trades at $0.85. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score.

Frequently asked questions

What is Genprex Inc's stock price?

Genprex Inc (GNPX) trades at $0.85.

Is Genprex Inc overvalued?

Genprex Inc carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Genprex Inc (GNPX)?

The 12-month analyst consensus target is $7.50, about 781.2% above the current $0.85. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-160.80%

Beta-0.96

50D MA$1.10

200D MA$4.48

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.7M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

GNPX vs LLY →GNPX vs JNJ →GNPX vs ABBV →Stock screener →